3.38% -0.29

Y Mabs Therapeutics Inc (YMAB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Y Mabs Therapeutics Inc-Aktie (YMAB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	14.69% 19.93	23.36	20.45	20.75	20.25
Cost Of Revenue	2.84% 2.097	2.039	2.595	4.649	2.083
Gross Profit	16.37% 17.83	21.32	17.86	16.10	18.17
Operating Expenses	0.89% 24.74	24.52	25.61	23.32	25.67
Benefits Costs and Expenses	9.29% 26.40	24.16	28.01	26.87	26.64
Costs And Expenses	1.04% 26.84	26.56	28.20	27.97	27.75
Operating Income/Loss	115.94% -6.908	-3.199	-7.749	-7.223	-7.501
Income/Loss From Continuing Operations Before Tax	715.76% -6.469	-0.793	-7.56	-6.123	-6.39
Income Tax Expense/Benefit, Current	17.95% 0.16	0.195	0.187	0.179	-
Income Tax Expense/Benefit	17.95% 0.16	0.195	0.187	0.179	-
Income/Loss From Continuing Operations After Tax	570.95% -6.629	-0.988	-7.747	-6.302	-6.39
Net Income/Loss	570.95% -6.629	-0.988	-7.747	-6.302	-6.39
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	712.19K% 43.78	-0.00615	43.62	43.66	43.67
Diluted Average Shares	712.19K% 43.78	-0.00615	43.62	43.66	43.67
Basic Earnings Per Share	650.00% -0.15	-0.02	-0.18	-0.14	-0.15
Diluted Earnings Per Share	650.00% -0.15	-0.02	-0.18	-0.14	-0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%